Les Sulewski
Stock Analyst at Truist Securities
(0.18)
# 4,209
Out of 4,876 analysts
12
Total ratings
18.18%
Success rate
-30.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $25 | $16.76 | +49.16% | 1 | May 28, 2025 | |
| PCRX Pacira BioSciences | Upgrades: Hold | $8 → $25 | $23.48 | +6.47% | 6 | Jan 30, 2025 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $10 → $12 | $8.13 | +47.60% | 3 | Oct 2, 2024 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $40 → $42 | $29.93 | +40.33% | 2 | Aug 9, 2024 |
Teva Pharmaceutical Industries
May 28, 2025
Initiates: Buy
Price Target: $25
Current: $16.76
Upside: +49.16%
Pacira BioSciences
Jan 30, 2025
Upgrades: Hold
Price Target: $8 → $25
Current: $23.48
Upside: +6.47%
Amneal Pharmaceuticals
Oct 2, 2024
Maintains: Buy
Price Target: $10 → $12
Current: $8.13
Upside: +47.60%
Collegium Pharmaceutical
Aug 9, 2024
Maintains: Buy
Price Target: $40 → $42
Current: $29.93
Upside: +40.33%